Literature DB >> 10821325

Androgens and the control of skeletal muscle protein synthesis.

M Sheffield-Moore1.   

Abstract

Athletes have long supported the concept that anabolic steroids increase skeletal muscle mass. However, it was only recently that both testosterone and its synthetic analogue, oxandrolone, were proven capable of inducing myotrophic effects in postabsorptive human skeletal muscle. These findings have provided the physiological evidence that anabolic steroids deserve attention in the clinical arena as a pharmacological intervention against losses in lean body mass associated with age, disease, trauma and burn injury. However, we are lacking in vivo molecular evidence that would directly or indirectly link androgens and the androgen receptor with increases in skeletal muscle mass. Clearly, a need exists to link in vivo and in vitro studies from both the physiological and molecular arena as they relate to androgens and the control and regulation of skeletal muscle mass. In this brief review, newly discovered information and emerging theories relating to the direct, indirect, priming and antiglucocorticoid action of androgens on skeletal muscle will be presented.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10821325     DOI: 10.3109/07853890008998825

Source DB:  PubMed          Journal:  Ann Med        ISSN: 0785-3890            Impact factor:   4.709


  24 in total

Review 1.  Intramuscular Anabolic Signaling and Endocrine Response Following Resistance Exercise: Implications for Muscle Hypertrophy.

Authors:  Adam M Gonzalez; Jay R Hoffman; Jeffrey R Stout; David H Fukuda; Darryn S Willoughby
Journal:  Sports Med       Date:  2016-05       Impact factor: 11.136

2.  Nutrition, anabolism, and the wound healing process: an overview.

Authors:  Robert H Demling
Journal:  Eplasty       Date:  2009-02-03

Review 3.  Pathogenesis of muscle wasting in cancer cachexia: targeted anabolic and anticatabolic therapies.

Authors:  Kimberlee Burckart; Sorin Beca; Randall J Urban; Melinda Sheffield-Moore
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2010-07       Impact factor: 4.294

4.  Translational studies in older men using testosterone to treat sarcopenia.

Authors:  Randall J Urban; E L Dillon; S Choudhary; Y Zhao; A M Horstman; R G Tilton; M Sheffield-Moore
Journal:  Trans Am Clin Climatol Assoc       Date:  2014

Review 5.  Realising the Potential of Urine and Saliva as Diagnostic Tools in Sport and Exercise Medicine.

Authors:  Angus Lindsay; Joseph T Costello
Journal:  Sports Med       Date:  2017-01       Impact factor: 11.136

6.  Effects of testosterone supplement treatment in hypogonadal adult males with T2DM: a meta-analysis and systematic review.

Authors:  Jianzhong Zhang; Bin Yang; Wenhui Xiao; Xiao Li; Hongjun Li
Journal:  World J Urol       Date:  2018-03-06       Impact factor: 4.226

7.  Beneficial effects of extended growth hormone treatment after hospital discharge in pediatric burn patients.

Authors:  Rene Przkora; David N Herndon; Oscar E Suman; Marc G Jeschke; Walter J Meyer; David L Chinkes; Ronald P Mlcak; Ted Huang; Robert E Barrow
Journal:  Ann Surg       Date:  2006-06       Impact factor: 12.969

8.  Metabolic and hormonal changes of severely burned children receiving long-term oxandrolone treatment.

Authors:  Rene Przkora; Marc G Jeschke; Robert E Barrow; Oscar E Suman; Walter J Meyer; Celeste C Finnerty; Arthur P Sanford; Jong Lee; David L Chinkes; Ronald P Mlcak; David N Herndon
Journal:  Ann Surg       Date:  2005-09       Impact factor: 12.969

9.  The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn.

Authors:  Marc G Jeschke; Celeste C Finnerty; Oscar E Suman; Gabriela Kulp; Ronald P Mlcak; David N Herndon
Journal:  Ann Surg       Date:  2007-09       Impact factor: 12.969

10.  Nonmyocytic androgen receptor regulates the sexually dimorphic development of the embryonic bulbocavernosus muscle.

Authors:  Lerrie Ann Ipulan; Kentaro Suzuki; Yuki Sakamoto; Aki Murashima; Yuuki Imai; Akiko Omori; Naomi Nakagata; Ryuichi Nishinakamura; Petr Valasek; Gen Yamada
Journal:  Endocrinology       Date:  2014-04-17       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.